1. Introduction
Hemipelvectomy is a surgical procedure involving pelvic resection, indicated for tumors in this anatomical location. It can be further classified as internal (with limb preservation) or external (without limb preservation). Both types have advantages and disadvantages, as well as technical difficulties and complications, due to the complex regional anatomy of the pelvis.
Resection in an internal hemipelvectomy can affect zones I–IV of the pelvis [
1], sometimes in a combined manner. Bone reconstruction may or may not be necessary, especially after resection of zones I and III. Although decided individually for each patient, options include iliofemoral pseudoarthrosis or arthrodesis using different grafts (allograft, free vascularized fibular graft, vascularized fibular autograft, or autoclaved autograft) or prosthetic reconstruction. Customized prosthetic reconstruction, supported by new technologies, is currently preferred, though this remains controversial [
2,
3,
4,
5,
6].
Pelvic structures necessary for lower limb function include the sciatic nerve, femoral neurovascular bundle, and periacetabular region of the pelvis. If tumor resection requires removal of two of these three critical anatomic structures, the patient will have a nonfunctional limb and an external hemipelvectomy would be recommended [
7]. This can be performed through the ilium (modified or conservative), sacroiliac joint (standard or classic), or sacral foramina (extended) [
8,
9,
10]. Soft tissue coverage can be achieved using a posterior (gluteal) or anterior flap, although other myocutaneous flaps can also be used, including rectus abdominis flaps, ipsilateral external oblique flaps [
11], and flaps from the amputated limb itself [
12].
The incidence of limb-sparing procedures performed for treating musculoskeletal tumors is increasing, facilitated by the development of new technologies. Moreover, current society interprets mutilating procedures as therapeutic failures. For both these reasons, in addition to its inherent morbidity and mortality, external hemipelvectomy seems to have become an obsolete technique, as already stated in some classic articles [
13]. This study intends to revisit external hemipelvectomy in the context of soft tissue sarcomas (STS), providing an updated literature review and two case reports that demonstrate unique presentations and behaviors.
4. Discussion
Currently, amputations performed in orthopedic surgical oncology are often perceived by society and a large part of the medical community as a sign of treatment failure. This may be the case when it is caused by a complication from a previous surgery, but not when it is selected as the primary treatment for an aggressive or malignant tumor that cannot be resected with clear margins or when resection is followed by a dysfunctional reconstruction. Compared with limb-conserving surgery, amputations are performed in approximately 10% of patient with sarcoma [
39]. These previous considerations are also applicable to hemipelvectomy, a procedure first performed by Billroth in 1891, although the patient survived only for a few hours. The first successful hemipelvectomy was performed in 1895 by Girard [
40].
In conservative surgery of soft tissue sarcomas of the pelvis girdle, preservation of the major neurovascular structures is a necessary condition, although resection of one or both main nerves does not represent an absolute contraindication for a conservative procedure [
13]. On the other hand, an ulcerated tumor would be [
41], as it was in the two cases presented in our study. Except for local recurrence after internal hemipelvectomy and palliative indications, external hemipelvectomy remains
a priori curative surgical procedure. Laitinen et al. recalled that in the modern era, the main indication for major pelvic resections, including hindquarter amputation, is for local control of malignant tumor [
33]. In this context, when treating malignant musculoskeletal tumors, the priority is to preserve life, then limb, and lastly, limb function.
The most common soft tissue sarcomas of the pelvic girdle are undifferentiated pleomorphic sarcoma and liposarcoma. Local surgical treatment is guided by the same principles as those of soft tissue sarcomas in other anatomical locations, albeit with the constraints of the previously described difficulties due to regional anatomy. Moreover, similar to bone sarcomas, most are diagnosed at a larger size compared with those usually found in other more accessible locations for physical examination. Furthermore, frequent involvement of soft tissues essential for coverage in internal hemipelvectomy compromises limb-sparing surgery.
Comparatively, and without distinguishing between bone sarcomas and soft tissue sarcomas, external and internal hemipelvectomies generally do not show significant differences regarding complications, with an overall mortality rate of ≤9% and a postoperative complication rate of 20–75% [
4,
41,
42,
43]. The most frequent complications are surgical wound infections and flap necrosis, especially in anterior flaps [
13,
42,
44]. Among all other possible complications, urogenital trauma is estimated to occur in 1.8–2.9% of cases [
4] and total complications in this anatomical region are between 8–18% [
43].
Flap necrosis treatment varies. However, it can be prevented by including the gluteus maximus muscle in posterior flaps, and the rectus femoris and vastus intermedius muscles in anterior flaps [
13]. Infections occur in 10–70% of patients due to different reasons [
4,
43,
45]. Guder et al. [
43] compared internal and external hemipelvectomies and reported that complications are more frequent in the former, especially in cases of reconstruction as well as type II and III resections, possibly due to the proximity and sacrifice of lymphatic vessels. Another case series showed that reconstructive procedures, while maintaining joint stability, are associated with more complications [
4,
32,
43]. A 2022 meta-analysis encourages the use of internal hemipelvectomy in pelvic sarcoma treatment, due to lower risk of surgical site infections [
32].
Regarding oncological outcomes, survival after a potentially curative hemipelvectomy depends on several factors, including tumor histology and size, disease stage, patient’s general condition, and resection type [
43,
46]. Whether the hemipelvectomy was internal or external is not as important [
32,
47]. However, mean survival in these patients is highly variable. If the patient is disease-free 5 years post-surgery, sarcoma-induced mortality risk is low [
48]. The same applies to local recurrences, except for bone chondrosarcoma, where late recurrences are more frequent.
Functional outcomes are particularly important following any type of hemipelvectomy. Regarding quality of life, no differences have been reported between internal and external hemipelvectomies, although those who underwent external hemipelvectomy report more phantom limb pain. Beck et al. reported that few of the patients who underwent hemipelvectomy were independent at discharge, although most were independent 6 years later with respect to daily living activities [
42]. However, long-term studies have also reported that limb function deteriorates after internal hemipelvectomy, decreasing by 23% over a follow-up period of 23–38 years [
48].
External hemipelvectomy often results in better mobility at discharge, although it subsequently causes more pain, increased bladder dysfunction, and difficulty climbing stairs in half of patients [
41,
42]. The same study showed that 4.4% of patients walked without external aids, 81% used crutches, 9% used wheelchairs, and 6% remained bedridden [
42]. Regarding the use of prostheses, most patients did not need them as they moved better without them, limiting their use for standing and cosmetic reasons. Of the four surviving patients who underwent external hemipelvectomy in a case series by Guder et al., two used wheelchairs (one for a short time) and the other two used crutches for short distances and wheelchairs for long distances [
43].
Emotional outcomes after hemipelvectomy have been poorly investigated in scientific literature and are often limited to the corresponding section of the Musculoskeletal Tumor Society scoring system (MSTS). Finally, financial implications are difficult to calculate accurately, since social costs due to various disabilities, prosthetic changes, and those affecting the overall quality of life should all be included [
49].
The two cases in our study exemplify the two extremes of the possible outcomes of an external hemipelvectomy: one good oncological and functional outcome and one poor outcome with multiple complications. Both serve to ensure that patients are properly informed prior to the procedure. Our first patient should be further discussed with respect to her pregnancy and subsequent delivery.
Only 14 deliveries after hemipelvectomy had been published in the literature until 2008 [
50], although other previous articles had reported a few isolated cases [
51,
52,
53]. Only two new cases have been published since then [
40,
54]. Although most tumors were bone tumors and flap type was unspecified, vaginal delivery remains possible. However, hemipelvectomy is associated with an increased risk of fetal malposition due to the altered pelvic anatomy and a caesarean section should be considered. In any case, a gynaecological assessment is essential.
Author Contributions
Conceptualization, L.R.R.P.; Methodology, L.R.R.P., P.C.R., and J.E.V.R.; Validation and Formal Analysis, P.C.R., L.C.G., M.E.N., E.V.G., J.C.C.P., M.M.F., and J.E.V.R.; Writing – Original Draft Preparation, L.R.R.P.; Writing – Review & Editing, L.R.R.P.; Visualization, P.C.R., L.C.G., M.E.N., E.V.G., J.C.C.P., M.M.F., and J.E.V.R.; Supervision, L.R.R.P.; Funding Acquisition, J.E.V.R. L.R.R.P.: Attending surgeon specialized in Orthopedic Oncology. Main surgeon of the cases, involved in drafting and revising of the manuscript. Corresponding author. Developed the study concept, did the final data analysis and provided the major clinical input in writing and revising of the manuscript. P.C.R.: Attending surgeon specialized in Orthopedic Oncology. She took part in the patient's surgery and contacted her to acquire the data for the study. She was involved in methodology and revising of the manuscript. L.C.G.: Attending surgeon specialized in Orthopedic Oncology. She contacted with the patient to acquire the data for the study. She was involved in revising of the manuscript. M.E.N.: Attending surgeon specialized in Orthopedic Oncology. He took part in the patient's surgery. She was involved in revising of the manuscript. E.V.G.: Attending surgeon specialized in Gynaecology and Obstetrics. She participated in the follow-up of the patient's pregnancy and delivery. She was involved in revising of the manuscript. J.C.C.P.: Attending surgeon specialized in Orthopedic Oncology. He was involved in revising of the manuscript. M.M.F.: Attending surgeon specialized in Orthopedic Oncology. She initially treated patient number 2 and referred her to our hospital. She was involved in revising of the manuscript. J.E.V.R.: Attending surgeon specialized in Orthopedic. He was involved in methodology and revising of the manuscript. Each autor has contributed significantly to, and is willing to take public responsibility for this study: its design, data acquisition, and analysis and interpretation of data. All authors have read and agreed to the published version of the manuscript.